Director/PDMR Shareholding
Summary by AI BETAClose X
IntegraFin Holdings plc (the "Company")
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
The Company announces that it was notified on 02 February 2026 that the trustee of the Company's Share Incentive Plan allocated ordinary shares of £0.01 each in the Company to the following Director of the Company/Person Discharging Managerial Responsibilities ("PDMR") as set out below:
|
|
Dividend Shares |
|
Alexander Scott |
413 |
These shares have been acquired by the trustee of the IntegraFin Share Incentive Plan 2018 by way of market purchase at a price of £3.56 per share.
The Notification of Dealing Form can be found below. This notification is provided in accordance with the requirements of the EU Market Abuse Regulation.
|
1. |
Details of the person discharging managerial responsibilities/person closely associated |
||||||
|
a) |
Name |
Alexander Scott
|
|||||
|
2. |
Reason for the notification
|
||||||
|
a) |
Position/status |
CEO |
|||||
|
b) |
Initial notification/Amendment |
Initial notification |
|||||
|
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
||||||
|
a) |
Name |
IntegraFin Holdings plc
|
|||||
|
b) |
LEI |
213800CYIZKXK9PQYE87
|
|||||
|
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
||||||
|
a) |
Description of the financial instrument, type of instrument
Identification code |
GB00BD45SH49 |
|||||
|
b) |
Nature of the transaction |
Purchase of ordinary shares by way of reinvestment of the December 2025 interim dividend under the Share Incentive Plan ("SIP") dividend reinvestment scheme. |
|||||
|
c) |
Price(s) and volume(s) |
|
|||||
|
d) |
Aggregated information
|
N/A
|
|||||
|
e) |
Date of the transaction |
2026-01-30; 11:44:09
|
|||||
|
f) |
Place of the transaction |
XLON |
|||||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 11 minutes ago City of London Investment Group
- 18 minutes ago BioPharma Credit
- 21 minutes ago BioPharma Credit
- 22 minutes ago Diageo
- 27 minutes ago Barr (A.G.)